Cis-2-(1,1-dimethylethyl)-1,2-dimethyl-cyclopropanecarboxylic acid, methyl ester - Compound Card

Cis-2-(1,1-dimethylethyl)-1,2-dimethyl-cyclopropanecarboxylic acid, methyl ester

Select a section from the left sidebar

Cis-2-(1,1-dimethylethyl)-1,2-dimethyl-cyclopropanecarboxylic acid, methyl ester

Structure
Zoomed Structure
  • Family: Plantae - Cannabaceae
  • Kingdom: Plantae
  • Class: Fatty Acid
Canonical Smiles [C@]1([C@@](C1)(C)C(C)(C)C)(C(=O)OC)C
InChI InChI=1S/C11H20O2/c1-9(2,3)11(5)7-10(11,4)8(12)13-6/h7H2,1-6H3/t10-,11+/m0/s1
InChIKey NXIPJVTUXCOECY-WDEREUQCSA-N
Formula C11H20O2
HBA 2
HBD 0
MW 184.28
Rotatable Bonds 1
TPSA 26.3
LogP 2.62
Number Rings 1
Number Aromatic Rings 0
Heavy Atom Count 13
Formal Charge 0
Fraction CSP3 0.91
Exact Mass 184.15
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Celtis africana Cannabaceae Plantae 266494

Showing of synonyms

  • Kudzanai IT, Evonia KN, et al. (2020). Antibacterial activity and gas chromatography mass spectrometry (GC–MS)-based metabolite profiles of Celtis africana and its endophytic extracts. Industrial Crops and Products, 2020,157, 112933. [View]

No compound-protein relationship available.

Structure

SMILES: C1CC1

Level: 0

Mol. Weight: 184.28 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.43
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.02
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.69

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.24
Plasma Protein Binding
65.16
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
9.7
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
1.29
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Toxic
Eye Irritation
Toxic
Maximum Tolerated Dose
0.4
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.08
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
0.82
Rat (Acute)
1.68
Rat (Chronic Oral)
1.42
Fathead Minnow
3.75
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
214.38
Hydration Free Energy
-2.03
Log(D) at pH=7.4
3.02
Log(P)
3.59
Log S
-3.24
Log(Vapor Pressure)
-0.96
Melting Point
1.95
pKa Acid
12.44
pKa Basic
5.66
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Type IV / VI secretion system DotU domain-containing protein Q9KN50 Q9KN50_VIBCH Vibrio cholerae serotype O1 2 0.7854
ADP-ribosylation factor 1 P84077 ARF1_HUMAN Homo sapiens 2 0.7684
11-beta-hydroxysteroid dehydrogenase 1 P28845 DHI1_HUMAN Homo sapiens 2 0.7169

Download SDF